A carregar...
Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
AIMS: In this analysis, we utilized data from PARADIGM‐HF to test the hypothesis that participants who exhibited any dose reduction during the trial would have similar benefits from lower doses of sacubitril/valsartan relative to lower doses of enalapril. METHODS AND RESULTS: In a post‐hoc analysis...
Na minha lista:
Publicado no: | Eur J Heart Fail |
---|---|
Main Authors: | , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley & Sons, Ltd
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5095784/ https://ncbi.nlm.nih.gov/pubmed/27283779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.580 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|